1
Name of Determination
1 Name of Determination
(1) This Determination is the National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010. (2) This Determination may also be cited as PB 1 of 2010.
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Commonwealth legislation
This Act has been repealed and is no longer in force. It is retained for historical reference.
This Determination groups specific prescription medicines into "therapeutic groups" for the Pharmaceutical Benefits Scheme (PBS).
What it does:
Who it affects:
Why it matters: Grouping drugs this way helps control healthcare costs and streamline the subsidy system by treating therapeutically similar medicines as alternatives within the same category.
Want the full deep dive?
Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.
Direct links to the current provisions in National Health (Pharmaceutical Benefits - Therapeutic Groups) Determination 2010 (No. PB 1 of 2010).
(1) This Determination is the National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010. (2) This Determination may also be cited as PB 1 of 2010.
In this Determination:
Act means the National Health Act 1953.
ATRA group means the Angiotensin II receptor antagonist group.
H2RA group means the H2 receptor antagonist group.
For paragraph 84AG(1)(a) of the Act, a therapeutic group is a group mentioned in a Part of Schedule 1.
For paragraph 84AG(1)(b), each listed drug mentioned in a Part of Schedule 1 is in the therapeutic group mentioned in the Part.
| Item | Listed drug |
|---|---|
| 2 | Eprosartan |
| 4 | Losartan |
| Item | Listed drug |
|---|---|
| 3 | Nizatidine |
Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.
(1) This Determination is the National Health (Pharmaceutical Benefits—Therapeutic Groups) Determination 2010. (2) This Determination may also be cited as PB 1 of 2010.
In this Determination:
Act means the National Health Act 1953.
ATRA group means the Angiotensin II receptor antagonist group.
H2RA group means the H2 receptor antagonist group.
For paragraph 84AG(1)(a) of the Act, a therapeutic group is a group mentioned in a Part of Schedule 1.
For paragraph 84AG(1)(b), each listed drug mentioned in a Part of Schedule 1 is in the therapeutic group mentioned in the Part.
| Item | Listed drug |
|---|---|
| 2 | Eprosartan |
| 4 | Losartan |
| Item | Listed drug |
|---|---|
| 3 | Nizatidine |